Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideshi Kawakami is active.

Publication


Featured researches published by Hideshi Kawakami.


Nature Genetics | 1994

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

Yoshiya Kawaguchi; Toshihiro Okamoto; Masafumi Taniwaki; Megumi Aizawa; Miho Inoue; Sadao Katayama; Hideshi Kawakami; Shigenobu Nakamura; Masaki Nishimura; Ichiro Akiguchi; Jun Kimura; Shuh Narumiya; Akira Kakizuka

We have identified a novel gene containing CAG repeats and mapped it to chromosome 14q32.1, the genetic locus for Machado-Joseph disease (MJD). In normal individuals the gene contains between 13 and 36 CAG repeats, whereas most of the clinically diagnosed patients and all of the affected members of a family with the clinical and pathological diagnosis of MJD show expansion of the repeat-number (from 68–79). Southern blot analyses and genomic cloning demonstrates the existence of related genes. These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to MJD.


Nature Genetics | 2009

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda

To identify susceptibility variants for Parkinsons disease (PD), we performed a genome-wide association study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan. We identified a new susceptibility locus on 1q32 (P = 1.52 × 10−12) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 × 10−9). We also detected strong associations at SNCA on 4q22 (P = 7.35 × 10−17) and LRRK2 on 12q12 (P = 2.72 × 10−8), both of which are implicated in autosomal dominant forms of parkinsonism. By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences. Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.


Nature | 2010

Mutations of optineurin in amyotrophic lateral sclerosis

Hirofumi Maruyama; Hiroyuki Morino; Hidefumi Ito; Yuishin Izumi; Hidemasa Kato; Yasuhito Watanabe; Yoshimi Kinoshita; Masaki Kamada; Hiroyuki Nodera; Hidenori Suzuki; Osamu Komure; Shinya Matsuura; Keitaro Kobatake; Nobutoshi Morimoto; Koji Abe; Naoki Suzuki; Masashi Aoki; Akihiro Kawata; Takeshi Hirai; Takeo Kato; Kazumasa Ogasawara; Asao Hirano; Toru Takumi; Hirofumi Kusaka; Koichi Hagiwara; Ryuji Kaji; Hideshi Kawakami

Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary motor cortex, brainstem and spinal cord. Most cases of ALS are sporadic, but about 10% are familial. Genes known to cause classic familial ALS (FALS) are superoxide dismutase 1 (SOD1), ANG encoding angiogenin, TARDP encoding transactive response (TAR) DNA-binding protein TDP-43 (ref. 4) and fused in sarcoma/translated in liposarcoma (FUS, also known as TLS). However, these genetic defects occur in only about 20–30% of cases of FALS, and most genes causing FALS are unknown. Here we show that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG), in patients with ALS. We found three types of mutation of OPTN: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous E478G missense mutation within its ubiquitin-binding domain. Analysis of cell transfection showed that the nonsense and missense mutations of OPTN abolished the inhibition of activation of nuclear factor kappa B (NF-κB), and the E478G mutation revealed a cytoplasmic distribution different from that of the wild type or a POAG mutation. A case with the E478G mutation showed OPTN-immunoreactive cytoplasmic inclusions. Furthermore, TDP-43- or SOD1-positive inclusions of sporadic and SOD1 cases of ALS were also noticeably immunolabelled by anti-OPTN antibodies. Our findings strongly suggest that OPTN is involved in the pathogenesis of ALS. They also indicate that NF-κB inhibitors could be used to treat ALS and that transgenic mice bearing various mutations of OPTN will be relevant in developing new drugs for this disorder.


Journal of the Neurological Sciences | 2006

High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease

Hiroki Tamura; Hideshi Kawakami; Takashi Kanamoto; Tomoko Kato; Tomoko Yokoyama; Ken Sasaki; Yuishin Izumi; Masayasu Matsumoto; Hiromu K. Mishima

The clinical and genetic relationships between Alzheimers disease (AD) and glaucoma remain obscure. The aim of this study was to determine the prevalence of open-angle glaucoma (OAG) in patients with AD and whether the apolipoprotein E (APOE) 4 allele is associated with AD, with or without OAG, in Japanese. The groups consisted of 172 patients with the diagnostic criteria of AD and 176 age-matched controls. Ophthalmic examinations were conducted, and genomic analysis was performed by PCR and digestion of products with an enzyme. OAG was found in 41 (23.8%) of the AD patients, which was a significantly (p = 0.0002) higher prevalence than that in the controls (9.9%). Furthermore, there was no significant difference between intraocular pressures (IOPs) in AD patients with OAG and without OAG. The percentage of AD patients who carried an APOE epsilon4 allele (29.5%) was significantly (p = 0.0007) higher than that of the controls (9.1%). However, the percentage of AD patients with OAG who carried an APOE epsilon4 allele (35.7%) was not significantly different than that of AD patients without OAG (27.7%, p = 0.42). In summary, the prevalence of OAG is high in Japanese patients with AD, suggesting that common factors other than APOE may contribute to the two diseases.


Cell Reports | 2015

Self-Organization of Polarized Cerebellar Tissue in 3D Culture of Human Pluripotent Stem Cells

Keiko Muguruma; Ayaka Nishiyama; Hideshi Kawakami; Kouichi Hashimoto; Yoshiki Sasai

During cerebellar development, the main portion of the cerebellar plate neuroepithelium gives birth to Purkinje cells and interneurons, whereas the rhombic lip, the germinal zone at its dorsal edge, generates granule cells and cerebellar nuclei neurons. However, it remains elusive how these components cooperate to form the intricate cerebellar structure. Here, we found that a polarized cerebellar structure self-organizes in 3D human embryonic stem cell (ESC) culture. The self-organized neuroepithelium differentiates into electrophysiologically functional Purkinje cells. The addition of fibroblast growth factor 19 (FGF19) promotes spontaneous generation of dorsoventrally polarized neural-tube-like structures at the level of the cerebellum. Furthermore, addition of SDF1 and FGF19 promotes the generation of a continuous cerebellar plate neuroepithelium with rhombic-lip-like structure at one end and a three-layer cytoarchitecture similar to the embryonic cerebellum. Thus, human-ESC-derived cerebellar progenitors exhibit substantial self-organizing potential for generating a polarized structure reminiscent of the early human cerebellum at the first trimester.


Lancet Neurology | 2006

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson’s disease: a large-scale international study

Alexis Elbaz; Lorene M. Nelson; Haydeh Payami; John P. A. Ioannidis; Brian K. Fiske; Grazia Annesi; Andrea Carmine Belin; Stewart A. Factor; Carlo Ferrarese; Georgios M. Hadjigeorgiou; Donald S. Higgins; Hideshi Kawakami; Rejko Krüger; Karen Marder; Richard Mayeux; George D. Mellick; John G. Nutt; Beate Ritz; Ali Samii; Caroline M. Tanner; Christine Van Broeckhoven; Stephen K. Van Den Eeden; Karin Wirdefeldt; Cyrus P. Zabetian; Marie Dehem; Jennifer S. Montimurro; Audrey Southwick; Richard M. Myers; Thomas A Trikalinos

BACKGROUND A genome-wide association study identified 13 single-nucleotide polymorphisms (SNPs) significantly associated with Parkinsons disease. Small-scale replication studies were largely non-confirmatory, but a meta-analysis that included data from the original study could not exclude all SNP associations, leaving relevance of several markers uncertain. METHODS Investigators from three Michael J Fox Foundation for Parkinsons Research-funded genetics consortia-comprising 14 teams-contributed DNA samples from 5526 patients with Parkinsons disease and 6682 controls, which were genotyped for the 13 SNPs. Most (88%) participants were of white, non-Hispanic descent. We assessed log-additive genetic effects using fixed and random effects models stratified by team and ethnic origin, and tested for heterogeneity across strata. A meta-analysis was undertaken that incorporated data from the original genome-wide study as well as subsequent replication studies. FINDINGS In fixed and random-effects models no associations with any of the 13 SNPs were identified (odds ratios 0.89 to 1.09). Heterogeneity between studies and between ethnic groups was low for all SNPs. Subgroup analyses by age at study entry, ethnic origin, sex, and family history did not show any consistent associations. In our meta-analysis, no SNP showed significant association (summary odds ratios 0.95 to 1.08); there was little heterogeneity except for SNP rs7520966. INTERPRETATION Our results do not lend support to the finding that the 13 SNPs reported in the original genome-wide association study are genetic susceptibility factors for Parkinsons disease.


Retina-the Journal of Retinal and Vitreous Diseases | 2006

No Association Of Complement Factor H Gene Polymorphism And Age-related Macular Degeneration In The Japanese Population

Junko Uka; Hiroki Tamura; Takayuki Kobayashi; Ken Yamane; Hideshi Kawakami; Atsushi Minamoto; Hiromu K. Mishima

Purpose: The aim of this study was to determine whether genetic polymorphism of complement factor H (CFH) is associated with age-related macular degeneration (AMD) in the Japanese population. Methods: Genomic DNA was examined in a cohort of 67 Japanese patients with AMD and 107 controls. TT/TC/CC genotypes on exon 9 were screened for sequence alternation by polymerase chain reaction analysis and through sequencing. Results: The mean ages ± SD of AMD patients and control subjects were 73 ± 8.5 years and 72 ± 8.7 years, respectively. There was no significant difference between CFH genotypes in the AMD group (TT, 76%; TC, 19%; CC, 5%) and the control group (TT, 80%; TC, 17%; CC, 3%). The frequencies of T and C alleles were 86% and 14%, respectively, in the AMD group and 89% and 11%, respectively, in the control group. Conclusion: CFH gene polymorphism is not associated with AMD in the Japanese population. Moreover, the frequency of the C allele is low among the Japanese population.


Neuroscience Letters | 2001

Genetic studies in Parkinson's disease with an α-synuclein/nacp gene polymorphism in Japan

Yuishin Izumi; Hiroyuki Morino; Masaya Oda; Hirofumi Maruyama; Fukashi Udaka; Masakuni Kameyama; Sigenobu Nakamura; Hideshi Kawakami

Dinucleotide repeat polymorphism has been observed in the promoter of the α-synuclein (α-SYN)/NAC precursor protein (NACP) gene. α-SYN/NACP allele 3 (described by Xia et al. (Ann. Neurol., 40 (1996) 207), equivalent to allele 1 described by Kruger et al. (Ann. Neurol. 45 (1999) 611) is reported to be significantly more frequent among patients with sporadic Parkinsons disease (sPD) than controls. In this study, we genotyped the same α-SYN/NACP polymorphism in Japanese sPD patients and healthy controls, but found that any allele showed no significant difference between the two groups.


American Journal of Human Genetics | 2003

SCA8 Repeat Expansion: Large CTA/CTG Repeat Alleles Are More Common in Ataxic Patients, Including Those with SCA6

Yuishin Izumi; Hirofumi Maruyama; Masaya Oda; Hiroyuki Morino; Takayuki Okada; Hidefumi Ito; Iwao Sasaki; Hiroyasu Tanaka; Osamu Komure; Fukashi Udaka; Shigenobu Nakamura; Hideshi Kawakami

We analyzed the SCA8 CTA/CTG repeat in a large group of Japanese subjects. The frequency of large alleles (85-399 CTA/CTG repeats) was 1.9% in spinocerebellar ataxia (SCA), 0.4% in Parkinson disease, 0.3% in Alzheimer disease, and 0% in a healthy control group; the frequency was significantly higher in the group with SCA than in the control group. Homozygotes for large alleles were observed only in the group with SCA. In five patients with SCA from two families, a large SCA8 CTA/CTG repeat and a large SCA6 CAG repeat coexisted. Age at onset was correlated with SCA8 repeats rather than SCA6 repeats in these five patients. In one of these families, at least one patient showed only a large SCA8 CTA/CTG repeat allele, with no large SCA6 CAG repeat allele. We speculate that the presence of a large SCA8 CTA/CTG repeat allele influences the function of channels such as alpha(1A)-voltage-dependent calcium channel through changing or aberrant splicing, resulting in the development of cerebellar ataxia, especially in homozygous patients.


Journal of Biological Chemistry | 2005

Mutant protein kinase Cγ found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death

Takahiro Seki; Naoko Adachi; Yoshitaka Ono; Hideki Mochizuki; Keiko Hiramoto; Taku Amano; Hiroaki Matsubayashi; Masayasu Matsumoto; Hideshi Kawakami; Naoaki Saito; Norio Sakai

Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disease characterized by various symptoms including cerebellar ataxia. Recently, several missense mutations in the protein kinase Cγ (γPKC) gene have been found in different SCA14 families. To elucidate how the mutant γPKC causes SCA14, we examined the molecular properties of seven mutant (H101Y, G118D, S119P, S119F, Q127R, G128D, and F643L) γPKCs fused with green fluorescent protein (γPKC-GFP). Wild-type γPKC-GFP was expressed ubiquitously in the cytoplasm of CHO cells, whereas mutant γPKC-GFP tended to aggregate in the cytoplasm. The insolubility of mutant γPKC-GFP to Triton X-100 was increased and correlated with the extent of aggregation. γPKC-GFP in the Triton-insoluble fraction was rarely phosphorylated at Thr514, whereas γPKC-GFP in the Triton-soluble fraction was phosphorylated. Furthermore, the stimulation of the P2Y receptor triggered the rapid aggregation of mutant γPKC-GFP within 10 min after transient translocation to the plasma membrane. Overexpression of the mutant γPKC-GFP caused cell death that was more prominent than wild type. The cytotoxicity was exacerbated in parallel with the expression level of the mutant. These results indicate that SCA14 mutations make γPKC form cytoplasmic aggregates, suggesting the involvement of this property in the etiology of SCA14.

Collaboration


Dive into the Hideshi Kawakami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryuji Kaji

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Hidefumi Ito

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaya Oda

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge